These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26207563)

  • 1. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results.
    Campari C; Fedato C; Iossa A; Petrelli A; Zorzi M; Anghinoni E; Bietta C; Brachini A; Brezzi S; Cogo C; Giordano L; Giorgi D; Palazzi M; Petrella M; Schivardi MR; Visioli CB; Giorgi Rossi P;
    Eur J Cancer Prev; 2016 Jul; 25(4):321-8. PubMed ID: 26207563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cervical and breast cancer screening among immigrant women resident in Italy].
    Francovich L; Di Napoli A; Giorgi Rossi P; Gargiulo L; Giordani B; Petrelli A
    Epidemiol Prev; 2017; 41(3-4 (Suppl 1)):18-25. PubMed ID: 28929723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
    Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
    PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation and risk of high grade cytological lesions among immigrants and Italian-born women in an organized cervical cancer screening program in Central Italy.
    Visioli CB; Crocetti E; Zappa M; Iossa A; Andersson KL; Bulgaresi P; Alfieri A; Amunni G
    J Immigr Minor Health; 2015 Jun; 17(3):670-8. PubMed ID: 24917238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.
    Campari C; Fedato C; Petrelli A; Zorzi M; Cogo C; Caprioglio A; Gallo F; Giordano L; Domenighini S; Pasquale L; Prandi S; Zappa M; Giorgi Rossi P;
    Infect Agent Cancer; 2015; 10():14. PubMed ID: 25969693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
    Pacchiarotti A; Ferrari F; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
    Int J Cancer; 2014 Feb; 134(4):897-904. PubMed ID: 23913416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].
    Giorgi Rossi P; Chini F; Borgia P; Guasticchi G; Carozzi FM; Confortini M; Angeloni C; Buzzoni C; Buonaguro FM;
    Epidemiol Prev; 2012; 36(2):108-19. PubMed ID: 22706361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer epidemiology in foreign women in Northern Italy: role of human papillomavirus prevalence in country of origin.
    Di Felice E; Caroli S; Paterlini L; Campari C; Prandi S; Giorgi Rossi P
    Eur J Cancer Prev; 2015 May; 24(3):223-30. PubMed ID: 25714783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
    Ronco G; Giubilato P; Carozzi F; Maia G; Giorgi Rossi P; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):61-76. PubMed ID: 26405778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immigration from countries with a strong migratory pressure and participation in cervical cancer screening program in the Local Health Unit 2, Umbria Region. Impact on the probability of high-grade lesions and cervical cancer].
    Vallesi G; Bietta C; Marri M; Petrella M
    Epidemiol Prev; 2012; 36(2):95-9. PubMed ID: 22706359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of cervical cancer screening results in women aged 50 and older in Beijing and Guizhou].
    Guo GZ; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):922-926. PubMed ID: 30605984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].
    Magnani C; Gillio Tos A; De Marco L; Calvia M; Cipelletti A; Bestagini P; Pagano E; Segnan N; Ronco G
    Epidemiol Prev; 2012; 36(2):88-94. PubMed ID: 22706358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young immigrant women and cervical cancer screening: participation and lesions detected at the first screening round.
    Battagello J; Monetti D; Rizzato S; Rosano A; Stocco CF; Zamberlan S; Rugge M; Zorzi M
    Epidemiol Prev; 2022; 46(3):173-180. PubMed ID: 35775295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.